Breaking Barriers: Denali Therapeutics Navigates FDA Meeting and Fast Tracks Tividenofusp Alfa for MPS-II Hunter Syndrome Treatment

Exciting News from Denali Therapeutics Inc. Accelerated Approval Pathway for Treating MPS II SOUTH SAN FRANCISCO, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) — Denali Therapeutics Inc. (Nasdaq: DNLI) has recently announced a breakthrough in their meeting with the Center for Drug Evaluation and Research (CDER) division of the U.S. Food and Drug Administration (FDA). This…

Read More

Breaking News: BioCryst’s Orladeyo (Berotralstat) Receives Approval from Israeli Ministry of Health

BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Israeli Ministry of Health RESEARCH TRIANGLE PARK, N.C., Nov. 28, 2022 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the Israeli Ministry of Health has granted marketing authorization for oral, once-daily ORLADEYO® (berotralstat) to prevent attacks of hereditary angioedema (HAE) in adults and pediatric…

Read More

Regis Corporation (RGS) Q2 2025 Earnings Call Transcript: Detailed Analysis of Professionally Educated and Intense Q&A Session

Regis Corporation (RGS) Q2 2025 Earnings Conference Call: On February 12, 2025, at 8:30 AM ET, Regis Corporation (RGS) held its second quarter earnings conference call. The call was led by Kersten Zupfer, Executive Vice President and Chief Financial Officer, and Matthew Doctor, President and Chief Executive Officer. Company Participants: Kersten Zupfer – Executive Vice…

Read More

Mantra DAO’s Om Token Soars to New Heights: A Fun and Quirky Look at Reaching 9.17 with Mantra-OM (#62080)

The Surprising Surge of Mantra (OM) in the Cryptocurrency Market The cryptocurrency market is abuzz with excitement as Mantra (OM), a relatively unknown digital asset, has recently hit a new all-time high of $9.17. This remarkable surge comes at a time when major cryptocurrencies like Bitcoin (BTC) and Ethereum (ETH) have either stagnated or seen…

Read More

Joining the Class Action Suit Against Intellia Therapeutics (INCTA): A Guide for Investors Who Suffered Financial Losses

Understanding the Intellia Therapeutics, Inc. (NTLA) Lawsuit: What It Means for Investors and the World On March 3, 2025, a press release was distributed by ACCESS Newswire announcing the filing of a securities class action lawsuit against Intellia Therapeutics, Inc. (NTLA) over alleged violations of the federal securities laws. The lawsuit, which is being led…

Read More

Target Corporation Shareholders Urged to Learn About Lead Plaintiff Opportunity in TGT Class Action Lawsuit by Robbins LLP Before Deadline

Class Action Lawsuit Filed Against Target Corporation: What Does It Mean for Investors and the World? On February 25, 2025, Robbins LLP announced the filing of a class action lawsuit against Target Corporation (TGT) on behalf of all investors who purchased or otherwise acquired the company’s stock between August 26, 2022, and November 19, 2024….

Read More